Shanghai Fenghe Information Technology (China)
我们诚恳邀请您参与我们的罕见病公益项目，以帮助那些需要支持的患者及其家庭。如果您有时间，我们欢迎您加入我们的团队；如果您能提供经济支持，我们将不胜感激。无论您选择捐款还是奉献时间，您所做的每一份贡献对我们的事业都是至关重要的。让我们携手合作，为罕见病患者带来希望和更美好的未来！ Ascendis Pharma A/S 正式宣布，其C型利钠肽(CNP)类似物YUVIWEL成功获得美国 FDA 授予的孤儿药独占权，目前已在美国全面实现商业化销售。 本网站旨在提高公众对公共健康新闻的认识并分享实时资讯。 我们关注罕见病的宣传，同时为了避免误导访客，我们声明本网站与任何公司或商标没有任何关联。
Basic Information
- Category: business
- Website: http://www.microsci.com/
Documented Facts
- Email: bttz@chinaicf.org (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Shanghai Fenghe Information Technology (China).
- Canonical profile: https://brandsource.ai/brands/shanghai-fenghe-information-technology-china
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/shanghai-fenghe-information-technology-china/json-ld
- Citation profile API: https://brandsource.ai/api/brands/shanghai-fenghe-information-technology-china/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
我们诚恳邀请您参与我们的罕见病公益项目，以帮助那些需要支持的患者及其家庭。如果您有时间，我们欢迎您加入我们的团队；如果您能提供经济支持，我们将不胜感激。无论您选择捐款还是奉献时间，您所做的每一份贡献对我们的事业都是至关重要的。让我们携手合作，为罕见病患者带来希望和更美好的未来！ Ascendis Pharma A/S 正式宣布，其C型利钠肽(CNP)类似物YUVIWEL成功获得美国 FDA 授予的孤儿药独占权，目前已在美国全面实现商业化销售。 本网站旨在提高公众对公共健康新闻的认识并分享实时资讯。 我们关注罕见病的宣传，同时为了避免误导访客，我们声明本网站与任何公司或商标没有任何关联。
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.